1. Optimising intracellular delivery of antibiotic loaded PLGA nanoparticles to macrophages.
- Author
-
Alsa'd AA, Greene MK, Tayyem M, Elmore B, Abed A, Burden RE, Gilmore BF, Scott CJ, and Burrows JF
- Subjects
- Animals, Mice, Humans, Particle Size, Drug Carriers chemistry, RAW 264.7 Cells, Rhodamines administration & dosage, Rhodamines chemistry, Cell Line, Coculture Techniques, Drug Delivery Systems, Polylactic Acid-Polyglycolic Acid Copolymer chemistry, Macrophages drug effects, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry, Nanoparticles chemistry, Staphylococcus aureus drug effects
- Abstract
Bacteria can evade antimicrobial therapy by hiding inside host cells such as macrophages. Here we examine the ability of PLGA nanoparticles to deliver antibiotics to intracellular bacteria, specifically focusing upon the impact of nanoparticle size. Different sized Rhodamine-B conjugated PLGA nanoparticles were synthesized and uptake examined in two macrophage cell lines, as well as different epithelial cells, to determine the optimal properties for macrophage uptake. These studies demonstrate macrophages display a consistent increase in uptake with increased PLGA nanoparticle diameter. In a bacteria-macrophage co-culture model, we then examined the efficacy of different sized antibiotic-loaded PLGA nanoparticles against intracellular infections with K. pneumoniae and S. aureus. Increasing the size of antibiotic-loaded PLGA nanoparticles significantly increased their potency against intracellular K. pneumoniae. However, this was not observed for S. aureus, potentially due to the observation these nanoparticles failed to access the compartment in which S. aureus reside. This work demonstrates for the first time that increasing the size of antibiotic-loaded PLGA nanoparticles can significantly enhance antimicrobial efficacy against K. pneumoniae intracellular macrophage infections. However, our S. aureus studies indicate this is not a 'one size fits all' approach for all intracellular infections., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF